Iqbal, Arham, Zaeem Ahmed Abbasi, and Fahad Naeem. “Benefits of Six Week and Personalized Dosing of Pembrolizumab Considering Ongoing Delta Variant Surge”. Journal of the Pakistan Medical Association 72, no. 3 (February 3, 2022). Accessed March 25, 2025. https://jpma.org.pk/index.php/public_html/article/view/4660.